Idea principal
In 267 working adults wearing Fitbit Charge 2 trackers for 14 days, more variable nighttime heart rate and less regular step rhythms went with more depressive symptoms, but detection was limited in the whole sample. The 80% accuracy came only from contrasting depressed participants with those who had no or minimal symptoms, which is much easier than real-world screening.
Study design
Estudio transversal
Reading basis
Published abstract
Reading focus
Association & confounding
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
About half of depression cases go undiagnosed and untreated, so cheap, unobtrusive screening would help. The authors tested whether behavior and physiology measured by consumer wearables (digital biomarkers) can detect risk of depression in a working population.
Población y método
Cross-sectional study of 290 healthy working adults, of whom 267 were analysed. Participants wore Fitbit Charge 2 devices for 14 consecutive days and completed health surveys, including the 9-item Patient Health Questionnaire (PHQ-9), at baseline and 2 weeks later. Biomarkers of activity, sleep and circadian rhythm were derived from steps, heart rate, energy expenditure and sleep data. Associations were tested with Spearman correlation and multiple regression adjusted for sociodemographics, alcohol, smoking, self-rated health, subjective sleep and loneliness. Supervised machine learning was evaluated with k-fold cross-validation on holdout folds, using varying PHQ-9 cutoffs.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Greater depressive symptom severity was robustly associated with more variable nighttime heart rate between 2 AM and 4 AM and between 4 AM and 6 AM.
- 2Greater severity was also associated with less regular weekday circadian rhythms based on steps (interdaily stability and autocorrelation) and with fewer step-based daily peaks.
- 3Despite these reliable associations, the digital biomarkers showed limited ability to detect depression in the whole sample.
- 4In balanced subsamples contrasting depressed participants with healthy participants who had no or minimal symptoms, the model reached 80% accuracy, 82% sensitivity and 78% specificity for identifying people at high risk of depression.
Límites e incertidumbre
- 1The strong accuracy figures come from deliberately contrasted subsamples that leave out the mild-to-moderate middle, so they overstate performance in a normal mixed workforce.
- 2The sample was small and fairly homogeneous: mean age 33, 79.0% Chinese, 89.1% with a university degree, and 63.7% female.
- 3Depression risk was defined by a self-report questionnaire (PHQ-9), not a clinical diagnosis, and the design is cross-sectional so it cannot show which came first.
- 4Participants wore one device model for 14 days, so findings may not carry over to other wearables or longer periods. This reading is based on the abstract only.
Relevancia práctica
Your tracker's sleep, heart rate and step patterns are not a depression test, and this study found limited ability to detect depression across a general group. The patterns it found, such as irregular daily rhythms, are only loose signals. If you feel low for weeks or worry about your mood, talk with a clinician rather than relying on device data.
Tus datos
Night-time heart rate variability across the night and the regularity of your daily step rhythm are the kinds of numbers this study looked at. If you watch them, use the same device and wear pattern, and look at multi-week trends rather than single nights.
Cómo interpretar la evidencia
Measurements are taken in the same period. Direction and causation usually cannot be determined; symptoms can change behaviour as well as the reverse.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Background
Depression is a prevalent mental disorder that is undiagnosed and untreated in half of all cases. Wearable activity trackers collect fine-grained sensor data characterizing the behavior and physiology of users (ie, digital biomarkers), which could be used for timely, unobtrusive, and scalable depression screening.
Objective
The aim of this study was to examine the predictive ability of digital biomarkers, based on sensor data from consumer-grade wearables, to detect risk of depression in a working population.
Methods
This was a cross-sectional study of 290 healthy working adults. Participants wore Fitbit Charge 2 devices for 14 consecutive days and completed a health survey, including screening for depressive symptoms using the 9-item Patient Health Questionnaire (PHQ-9), at baseline and 2 weeks later. We extracted a range of known and novel digital biomarkers characterizing physical activity, sleep patterns, and circadian rhythms from wearables using steps, heart rate, energy expenditure, and sleep data. Associations between severity of depressive symptoms and digital biomarkers were examined with Spearman correlation and multiple regression analyses adjusted for potential confounders, including sociodemographic characteristics, alcohol consumption, smoking, self-rated health, subjective sleep characteristics, and loneliness. Supervised machine learning with statistically selected digital biomarkers was used to predict risk of depression (ie, symptom severity and screening status). We used varying cutoff scores from an acceptable PHQ-9 score range to define the depression group and different subsamples for classification, while the set of statistically selected digital biomarkers remained the same. For the performance evaluation, we used k-fold cross-validation and obtained accuracy measures from the holdout folds.
Results
A total of 267 participants were included in the analysis. The mean age of the participants was 33 (SD 8.6, range 21-64) years. Out of 267 participants, there was a mild female bias displayed (n=170, 63.7%). The majority of the participants were Chinese (n=211, 79.0%), single (n=163, 61.0%), and had a university degree (n=238, 89.1%). We found that a greater severity of depressive symptoms was robustly associated with greater variation of nighttime heart rate between 2 AM and 4 AM and between 4 AM and 6 AM; it was also associated with lower regularity of weekday circadian rhythms based on steps and estimated with nonparametric measures of interdaily stability and autocorrelation as well as fewer steps-based daily peaks. Despite several reliable associations, our evidence showed limited ability of digital biomarkers to detect depression in the whole sample of working adults. However, in balanced and contrasted subsamples comprised of depressed and healthy participants with no risk of depression (ie, no or minimal depressive symptoms), the model achieved an accuracy of 80%, a sensitivity of 82%, and a specificity of 78% in detecting subjects at high risk of depression.
Conclusions
Digital biomarkers that have been discovered and are based on behavioral and physiological data from consumer wearables could detect increased risk of depression and have the potential to assist in depression screening, yet current evidence shows limited predictive ability. Machine learning models combining these digital biomarkers could discriminate between individuals with a high risk of depression and individuals with no risk.
Fuentes y atribución
Digital Biomarkers for Depression Screening With Wearable Devices: Cross-sectional Study With Machine Learning Modeling.
Rykov Y, Thach TQ, Bojic I, Christopoulos G, Car J.
JMIR mHealth and uHealth · 2021-10-25
DOI: 10.2196/24872 ↗PubMed · 34694233 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Activity–stroke and heart attack curves differ by accelerometer processing method
Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.
Preventive Medicine
Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven
A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.
Forensic Science International
Activity trackers: about 1,800 more steps a day, but small effects on other outcomes
An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.
The Lancet Digital Health
Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages
In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.
Sleep

